Investing.com - JCR Pharmaceuticals reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
JCR Pharmaceuticals announced earnings per share of ¥-3.3 on revenue of ¥6.0. Analysts polled by Investing.com EPS of ¥-1.2 on revenue of ¥7.73B.
JCR Pharmaceuticals 's are down 16.97% and is trading at ¥2,123.0 , still down 28.85% from its 52 week high of ¥2,984.00 set on Friday, October 29, 2021.
JCR Pharmaceuticals follows other major Healthcare sector earnings this month
JCR Pharmaceuticals's report follows an earnings missed by Chugai Pharmaceutical on Monday, who reported EPS of ¥41.21 on revenue of ¥225.3B, EPS of ¥49.44 on revenue of ¥288.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar